DYAX
Dyax Corp
Dyax was a biopharmaceutical company that made KALBITOR, an injectable medicine used to stop the painful swelling attacks of a rare inherited condition called hereditary angioedema. It took its name in 1995, when a merger of Biotage and Protein Engineering Corporation created the Cambridge, Massachusetts firm. Its science leaned on a quirky technique called phage display, which uses the shells of harmless bacteria viruses to help uncover new drug candidates.
CUSIP: 26746E103HealthcareUS1 holder
Total Value
$25.35M
Total Shares
673.9K
Net Share Change
+2.5K
Activity
1 buying
Investor
Value
Shares
Weight
Change
